TAG:
diagnostic assays
Lab Testing to Boom During This Decade
By Robert Michel | From the Volume IX No. 11 – August 5, 2002 Issue
CEO SUMMARY: Several recent acquisitions of lab test technology by billion-dollar diagnostics manufacturers reinforce a new reality in the healthcare marketplace: developing new diagnostic tests is faster, cheaper, and more profitable than developing new pharmaceutical products. This simp…
High Cost of New Assays Stretching Lab Budgets
By Robert Michel | From the Volume IX No. 7 – May 13, 2002 Issue
CEO SUMMARY: Growing numbers of hospital labs report that higher costs of new diagnostic tests have become a new management problem. That’s because diagnostic manufacturers are developing tests around a new business model, one that calls for higher pricing based on a premise of higher c…
Cytyc Acquires Digene To Expand Product Line
By Robert Michel | From the Volume IX No. 4 – March 11, 2002 Issue
CEO SUMMARY: Cytyc Corporation will pay more than one half billion dollars to purchase Digene, Inc., and its DNA Capture HPV test. For Cytyc, this may prove to be a strategic masterstroke. In the short term, it alters the competitive balance in the market for liquid preparation Pap testin…
How Dr. Al Nichols Changed The Lab Testing Marketplace
By Robert Michel | From the Volume IX No. 3 – February 18, 2002 Issue
CEO SUMMARY: At a time when lab testing meant routine assays performed within a few miles of the collection, Albert L. Nichols, M.D. envisioned a centralized national laboratory devoted to performing specialized, highly-complex testing to clinicians everywhere. Not only did his vision bec…
ARUP Labs, ProxyMed, Unilab, Quest Diagnostics, Ventana, , Misys Molecular Diagnostics, WebMD, Varian
By Robert Michel | From the Volume IX No. 3 – February 18, 2002 Issue
ARUP TO USE PROXYMED FOR BROWSER-BASED TEST ORDERS & RESULTS ARUP LABORATORIES, INC. and ProxyMed, Inc. signed an agreement that makes ProxyMed’s ProxyLabSM the preferred product for browser-based lab test ordering between physicians and ARUP’s hospi…
“February 26, 2001 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VIII No. 3 – February 26, 2001 Issue
Multiplex testing on a single specimen is getting ever closer to the clinical marketplace. On February 19, LINCO Research, Inc. and Luminex Corporation announced an agreement that calls for LINCO to develop, manufacture, and market multianalyte immunoassay kits using…
Business Premises Underlying Lab Industry Dynamics
By Robert Michel | From the Volume VII No. 18 – December 25, 2000 Issue
This chapter addresses the characteristics of the laboratory industry which define the starting point for changes and ongoing evolution. The eight business premises listed in this White Paper describe unique situations which directly influence the ability of clinical laboratories to serve the medical…
Ortho-Clinical Diagnostics Embraces New Testing Technology
By Robert Michel | From the Volume VII No. 17 – December 4, 2000 Issue
CEO SUMMARY: Despite a decade of consolidation, competition among the world’s largest diagnostics manufacturers remains intense. In response to this competition, Ortho-Clinical Diagnostics (OCD) is preparing a variety of new products and services for its clinical laboratory customers. I…
“November 13, 2000 Intelligence: Late Breaking Lab News”
By R. Lewis Dark | From the Volume VII No. 16 – November 13, 2000 Issue
Last Thursday was the day Dynacare, Inc. hoped to place its initial public offering. Dynacare seeks to raise as much as $89 million…
Specialty Labs Prepares For Public Stock Offering
By Robert Michel | From the Volume VII No. 14 – October 2, 2000 Issue
CEO SUMMARY: Stock prices for public lab companies zoomed upwards through 2000. For this reason, executives at Specialty Laboratories, Inc. believe it is an auspicious time for their laboratory to bring an initial public offering (IPO) to market. Company officials recently filed a stock r…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized